Thai Traditional Medical Knowledge Fund Report issue

Foundation Phase 1 Phase 2

Organization Overview

First Clinical Trial
2014
NCT02286453
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (4)

benjakul (1 trial)

diclofenac (voltaren) (1 trial)

ginger (1 trial)

loratadine (claritin) (1 trial)

Drugs in Phase 1 Trials (1)

prasaprohyai (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Rhinitis (Phase 2)

Rhinitis, Allergic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 5